BIO · Company KPIs
Bio-Rad (BIO) KPIs
Currency-neutral revenue growth. As reported in SEC filings, with the source line for each figure.
Currency-neutral revenue growth
-1.9% for the period ended Jun 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Jun 30, 2026 | -1.9% | Flat -60 bps -$18MFlat -1.9% CN*8-K filed 2026-08-04 |
| Mar 31, 2026 | -4.2% | $592M +1.1% -4.2% CN*8-K filed 2026-04-30 |
| Dec 31, 2025 | 1.7% | Currency neutral revenue growth (decline) · 1.7% · (2.3)% · (0.1)% · (3.6)%8-K filed 2026-02-12 |
| Sep 30, 2025 | -1.7% | Currency neutral revenue growth (decline) · (1.7)% · 3.4% · (0.7)% · (4.0)%8-K filed 2025-10-29 |
| Jun 30, 2025 | 1% | 2.1% YoY 1.0% YoY CN*8-K filed 2025-07-31 |
| Dec 31, 2024 | -2.3% | Currency neutral revenue growth (decline) · 1.7% · (2.3)% · (0.1)% · (3.6)%8-K filed 2026-02-12 |
| Sep 30, 2024 | 3.4% | Currency neutral revenue growth (decline) · (1.7)% · 3.4% · (0.7)% · (4.0)%8-K filed 2025-10-29 |
Reading notes
Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.